Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | ||||
| Depreciation Amortization | 18 | 1 | N/A | N/A |
| Accounts receivable | -141 | -93 | N/A | 4 |
| Other Working Capital | -165 | -144 | 1 | -362 |
| Other Operating Activity | 200 | 43 | -50 | 275 |
| Operating Cash Flow | $-87 | $-192 | $-49 | $-83 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -26 | -45 | N/A | N/A |
| Purchase Of Investment | -399 | N/A | N/A | N/A |
| Other Investing Activity | -32 | -309 | 0 | -2 |
| Investing Cash Flow | $-457 | $-354 | $0 | $-2 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 595 | 362 | N/A | 743 |
| Other Financing Activity | -71 | 150 | 0 | -514 |
| Financing Cash Flow | $524 | $512 | $0 | $229 |
| Beginning Cash Position | 59 | 97 | 146 | 0 |
| End Cash Position | 39 | 63 | 97 | 146 |
| Net Cash Flow | $-20 | $-34 | $-49 | $145 |
| Free Cash Flow | ||||
| Operating Cash Flow | -87 | -192 | -49 | -83 |
| Capital Expenditure | -26 | -45 | N/A | N/A |
| Free Cash Flow | -113 | -237 | -49 | -83 |